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Foreign nucleic acids, the signature of invading viruses and certain bacteria, are sensed intracellularly. The
nucleic acid-specific Toll-like receptors (TLRs) detect and signal within endolysosomal compartments,
triggering the induction of cytokines essential for the innate immune response. These cytokines include
proinflammatory molecules produced mainly by macrophages and conventional dendritic cells, as well as
type I interferons, which are produced in great quantities by plasmacytoid dendritic cells. The cellular and
molecular pathways by which nucleic acids and TLRs meet within the endosome assure host protection
yet also place the host at risk for the development of autoimmunity. Here, we review the latest findings on
the intracellular TLRs, with special emphasis on ligand uptake, receptor trafficking, signaling, and regulation.Introduction
The host resists infection in many different ways but, in one way or
another, must always discriminate self from nonself. Such
discrimination may depend upon sensing things that are dimin-
ished or absent during infection though present under normal
conditions. One example is the downregulation of class I MHC
molecules during many viral infections, a change that is
perceived by NK cells. Self-nonself discrimination may also
depend upon seeing concomitants of infection. This includes
changes in the intracellular milieu and the expression of mole-
cules indicative of ‘‘stress.’’ Microbial proteases may initiate
proteolytic cascades that culminate in the production of ligands
that initiate an innate immune response (Ferrandon et al., 2007).
But perhaps the most basic and broadly applied scheme for
self-nonself discrimination depends upon receptors for molec-
ular signatures unique to microbes and broadly represented
among microbial taxa. The existence of such signatures has
been known for many decades, and just over one decade ago,
Toll-like receptors (TLRs) were identified by genetic means as
the sensors that detect them. First LPS (Poltorak et al., 1998),
then DNA, RNA, lipopeptides, flagellin, and other components
of microbes were shown to be TLR ligands. In Drosophila, such
sensors also exist. These are the GNBPs and PGRPs (Ferrandon
et al., 2007). PGRP-SA and two of the GNBPs converge upon Toll,
the namesake of the TLRs, and the first member of the family
known to participate in microbe sensing (Lemaitre et al., 1996).
Because they are capable of recognizing molecules derived
from viruses, fungi, bacteria, and protozoa, the TLRs are able to
sense most of the infections we might ever encounter. And their
role in sensing is indispensable. The backup provided by other
sensors is inadequate to cope with most infections in the absence
of TLR signaling. Mice lacking MyD88 and TRIF, which cannot
generate signals via any of the TLRs or via the structurally related
IL-1, IL-18, and IL-33 receptors rarely survive to weaning age
without antibiotic support (Hoebe et al., 2003). Even mutations
affecting individual TLRs, such as TLR2 (Takeuchi et al., 2000),
TLR4 (Poltorak et al., 1998), or TLR9 (Tabeta et al., 2004), cause
quite obvious susceptibility to specific infectious agents.
All the same, there is considerable redundancy in systems that
detect microbes. One indication of this is the relative preserva-tion of adaptive immune responses in the absence of TLR
signaling. Conventional adjuvants drive strong adaptive immune
responses in the absence of TLR signaling (Gavin et al., 2006).
Redundancy is also to be seen in the augmentation of adaptive
immune responses witnessed during conventionalization of
germ-free mice with enteric microbes, which occurs even if
TLR signaling is abolished by mutations (Slack et al., 2009).
Thus, although TLRs do mediate adjuvant effects, adaptive
immune responses can nonetheless occur perfectly well in their
absence. It is now well understood that microbes can initiate an
adaptive response via several sensing pathways and, in most
cases, can do so even if there is no TLR signaling at all.
Another source of redundancy stems from the fact that each
species of microbe usually displays multiple TLR ligands in
addition to ligands that trigger other classes of innate immune
receptors, including the RIG-I-like helicases (RLHs) (Yoneyama
and Fujita, 2009), NOD-like receptors (NLRs) (Martinon et al.,
2007), or glycan receptors (Lee and Kim, 2007). A microbe that
evades one pathway will often be detected by another.
Yet, we provisionally assume that, not only in their ligand
specificity but in other characteristics as well, TLRs must each
make unique contributions to host resistance as a whole. If
they did not, we might expect they would be eliminated by the
pressure of random mutation. Here, we suggest that distinct
sensing pathways evolved to match the characteristics and
lifestyles of divergent microbes, which may be extracellular,
cytoplasmic, or resident within endosomal compartments. We
further consider that the host has evolved specialized cellular
defenses to cope with infection, wherein different cells of the
immune system and, indeed, all cells of the host may be en-
dowed with ‘‘optimized’’ systems for the perception of microbes,
often microbes with a set of common characteristics.
The TLR family includes receptors residing both at the cell
surface and intracellularly, highlighting the specialization of
receptor subsets for particular tasks. Many of the unique
properties of the intracellular receptors have only recently
been deciphered. In this review, we discuss the intracellular
TLRs, their ligands, their signaling, mutations that disrupt their
function, and their relationship to other receptors that detect
infection.Immunity 32, March 26, 2010 ª2010 Elsevier Inc. 305
Figure 1. Mechanisms for Internalization
of Nonself
The engulfment of solid particles by phagocytosis
can mediate uptake of whole bacteria and
dead cell fragments and is triggered by specific
receptors, including the mannose receptor, Fc
receptors, and scavenger receptors. Fluid
phase endocytosis, or macropinocytosis, allows
uptake of suspended or cell-adherent particles.
Receptor-mediated endocytosis via clathrin or
caveolin enables absorption of a variety of
particles and molecules, including nutrients and
pathogens. Ultimately, vesicles formed at the
plasma membrane fuse with mildly acidic early or
recycling endosomes. Phagosomes may directly
fuse with the highly acidic late endosomes or
lysosomes. Vesicle cargo is finally delivered to
lysosomes through fusion between late endo-
somes and lysosomes.
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Cells must survey the extracellular milieu for signs of infection,
and in doing so, they run the risk of being infected and killed
by microbes. For this reason, they internalize microbes into the
endocytic pathway: a hostile environment that is nonetheless
capable of detecting infection and reporting it, first to the phago-
cytic cell and then to other cells of the body. The endocytic
pathway accommodates molecules derived from cells and
microbes alike. It acquires them through diverse processes
that have much in common with one another yet are distinct
enough to codify (Figure 1).
Phagocytosis is triggered by specific receptors, including
the mannose receptor, complement receptor, Fc receptors,
phosphatidylserine receptor, and scavenger receptors. Phago-
cytic uptake requires actin cytoskeletal reorganization and is
critically dependent on Rho family GTPases, allowing protru-
sions from the membrane to wrap around the target and
engulf it (Groves et al., 2008). Ultimately, phagosomes fuse
with late endosomes or lysosomes, but phagosome dwell
time and the precise trafficking mechanism are dictated by
the identity of the uptake receptor and the nature of the cargo
(Conner and Schmid, 2003). Some cells are far more active at
phagocytosis than others, such as macrophages and polymor-
phonuclear leukocytes that are highly specialized for the
process.
Fluid phase endocytosis, or macropinocytosis, allows uptake
of suspended or cell-adherent particles. The mechanisms are
similar to phagocytosis in that actin cytoskeletal rearrangement
is necessary and depends upon Rho GTPases to create mem-
brane extensions, but in this case, multiple smaller particles
may be taken up in a bolus of liquid. Dendritic cells are particu-
larly adept at macropinocytosis, which results in the internaliza-
tion of comparatively large volumes of fluid from the extracellular
milieu (Mellman and Steinman, 2001).306 Immunity 32, March 26, 2010 ª2010 Elsevier Inc.Endocytosis mediated by caveolae
and clathrin (Conner and Schmid, 2003)
are both receptor mediated and transport
only limited quantities of fluids. Caveolin-
dependent endocytosis occurs at regions
of the membrane rich in cholesterol and
sphingolipids. Caveolin associates withcholesterol and itself to coat the surface of the invaginated
membrane. Clathrin forms a quasicrystalline coat on the inner
surface of the plasma membrane that invaginates into pits and
then buds to form a coated vesicle. These vesicles quickly
uncoat, allowing fusion with endosomes.
Vesicles formed at the membrane fuse with early endosomes
or recycling endosomes. The early endosomes act to sort cargo
and have a mildly acidic pH. In this compartment, ligands are
separated from their receptors, allowing the receptors to cycle
back to the cell surface (Maxfield and McGraw, 2004). Subse-
quently, endocytosed cargo is sorted to the late endosomes.
The late endosomes, also called multivesicular bodies because
they contain numerous intraluminal vesicles of cytoplasmic
material that have budded from the endosomal membrane, are
more acidic and are the final sorting location before delivery to
lysosomes (Mellman, 1996). Delivery of endosomal contents to
lysosomes occurs either through transient or stable membrane
fusions of late endosomes and lysosomes (Pryor and Luzio,
2009).
Intracellular TLR Ligand Recognition
The precise molecular interactions between TLRs and their
ligands have been determined in a number of cases. TLR spec-
ificity is sufficiently relaxed to permit accommodation of
numerous LPS isoforms and is perhaps enforced as much by a
proscription against recognition of host molecules rather than
inflexible rules concerning ligand structure (Beutler et al.,
2006). At times, endogenous ligands are recognized by TLRs
or by TLR coreceptors such as CD36 (Hoebe et al., 2005), and
these ligands may conceivably act as danger signals in the
setting of tissue damage (Miyake, 2007). As discussed below,
some TLRs do not seem to discriminate between molecules of
host and microbe origin at all and respond to either one should
an encounter occur.
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TLR12 of mice and TLR10 of humans are expressed largely on
the cell surface where they recognize molecules derived from
microbes of many types (Kawai and Akira, 2009; Kumar et al.,
2009). The intracellular TLRs, including TLR3, TLR7, TLR8, and
TLR9, are intrinsically capable of detecting nucleic acids. To
distinguish between host and foreign nucleic acids, these TLRs
act within the endosomal compartment, from which host DNA
is usually (but not always) excluded and do so at a particular
stage of endosome maturation and acidification. In mice,
TLR13 is believed to be located within endosomes because it
has been shown to associate with UNC93B1 (Brinkmann et al.,
2007), but its ligand remains unknown.
There is a strong sense that the intracellular TLRs function
primarily to detect viruses, although it has been shown that
they detect other microbes as well. Many viruses are perceived
only by endosomal TLRs, and the endosomal TLRs are particu-
larly important to their containment. As discussed above, uptake
of intact microbes into the endocytic pathway may occur by
receptor-mediated endocytosis, phagocytosis, or nonspecific
fluid phase endocytosis. Alternatively, viruses may fuse with
the plasma membrane and later be swept into the endosomes
either before or during the process of replication as a result of
autophagy (Lee et al., 2007). Fully replicated viruses may bud
into the endosomal system and traffic through the endosomes
on their way to being released from the cell (Wang et al., 2006b).
TLR9 was originally found to detect bacterial DNA. Its speci-
ficity was initially thought to be directed toward CpG motifs,
which are four times less abundant (and mostly methylated) in
mammalian genomic DNA than in bacterial or viral DNA. Thus,
TLR9 recognizes dsDNA viruses such as mouse cytomegalo-
virus (MCMV) and herpes simplex viruses 1 and 2 (Krug et al.,
2004a, 2004b; Lund et al., 2003) and the genomes of protozoa,
including Trypanosoma cruzi (Bafica et al., 2006). Although ma-
larial DNA is by itself only weakly stimulatory to TLR9, it induces
strong TLR9 responses when delivered to the endosomal
compartment with a transfection reagent or when bound to ma-
larial hemozoin (Parroche et al., 2007). Thus, hemozoin appears
to be a carrier that directs the parasitic DNA to the proper
compartment for detection, consistent with the rule that ligand
delivery is an essential condition for recognition by the intracel-
lular receptors.
Synthetic CpG oligonucleotides (ODN) containing phosphoro-
thioate linkages stimulate innate immune responses in a TLR9-
dependent manner and are commonly used in experimental
systems to study TLR9 responses. While there appear to be
specific sequences or modifications that optimize the response
to nucleic acid ligands (Wagner, 2008), recent work challenges
the dogma that unmethylated CpG motifs constitute the foreign
signature that triggers TLR9. In fact, it has now been shown
that DNA recognition by TLR9 depends on the 20 deoxyribose
phosphate backbone and that neither phosphorothioate link-
ages nor specific sequences (i.e., CpG motifs) are necessary
to induce a response (Haas et al., 2008; Yasuda et al., 2006).
Moreover, if nondenatured vertebrate DNA is delivered to the
endosomal pathway using a liposome transfection reagent, it
can stimulate TLR9 (Yasuda et al., 2005). Phosphorothioate link-
ages and CpG motifs in synthetic ligands likely increase the
stability, aggregation, and uptake of the DNA by cells but arenot necessary for interaction with TLR9. Thus, it is ultimately
localization to the endolysosomal compartment rather than the
sequence, species origin, covalent modification, or double-
versus single-strandedness of DNA that dictates TLR9 activation
(see below).
TLR7 recognizes ssRNA, imidazoquinoline derivatives such as
resiquimod (R848) and imiquimod, and guanine analogs such as
loxoribine (Diebold et al., 2004; Heil et al., 2004; Lund et al.,
2004). In particular, TLR7 recognizes guanosine- and uridine-
rich ssRNA, and synthetic polyuridines act as potent ligands.
Through TLR7, the host detects ssRNA viruses, including human
immunodeficiency virus (HIV), influenza, and vesicular stomatitis
virus (VSV). The host can also utilize TLR7 to detect Borrelia
burgdorferi and RNA released into endolysosomes by phagoso-
mal bacteria (Eberle et al., 2009; Mancuso et al., 2009; Petzke
et al., 2009). Finally, TLR7 may recognize some siRNAs (Hornung
et al., 2005). Humans, but not mice, also detect ssRNA through
TLR8 (Jurk et al., 2002). And TLR7 (and/or TLR8) is responsible
for the detection of host ribonucleoprotein complexes, some-
times with pathologic consequences as described below.
TLR3 is specific for dsRNA and also recognizes the synthetic
analog polyinosinic-polycytidylic acid (poly I:C). The dsRNA
ligand may be derived from the genomes of dsRNA viruses, for
example reovirus. Surprisingly, it was found that TLR3 is addi-
tionally able to recognize some ssRNA viruses, including West
Nile virus, respiratory syncytial virus (RSV), and encephalomyo-
carditis virus (EMCV), and even dsDNA viruses such as herpes
simplex virus and mouse cytomegalovirus (MCMV) (Tabeta
et al., 2004; Wang et al., 2004; Zhang et al., 2007) are sensed
via TLR3 responses. During infection, replication of positive
sense ssRNA viruses proceeds through a dsRNA intermediate,
and dsRNA may also be produced as a result of bidirectional
transcription of the genomes of dsDNA viruses. This dsRNA
may then be detected by TLR3 (Weber et al., 2006), resulting in
some redundancy in sensing of RNA viruses through TLR7 and
TLR3, and of DNA viruses through TLR9 and TLR3. Diversity in
the signaling pathways triggered by TLR3 versus TLR7 and
TLR9 may also allow for some selectivity in the responses that
occur after infection by different types of viruses.
Trafficking of Intracellular TLRs
TLR3, TLR7, TLR8, TLR9, and probably TLR13 of mice are
expressed intracellularly within the endoplasmic reticulum (ER),
endosomes, multivesicular bodies, and lysosomes. However,
activation only occurs within acidified endolysosomal compart-
ments, because TLR3, TLR7, TLR8, and TLR9 responses are
abrogated by bafilomycin A1, chloroquine, or ammonium chlo-
ride, which prevent acidification (Ha¨cker et al., 1998). Based
on microscopy studies and the finding that carbohydrates on
mature TLR9 lacked the posttranslational modifications typically
acquired in the Golgi, it was initially proposed that the intracel-
lular TLRs are ER resident and are quickly translocated to the
endolysosomes only upon activation (Latz et al., 2004; Leifer
et al., 2004). However, this model raised questions about the
nature of the atypical trafficking route utilized by these TLRs
and about how cells sense nucleic acids before the intracellular
TLRs are mobilized to an acidified endosomal compartment.
Analysis of the carbohydrates on endosomal TLR7 and TLR9
has since shown that the receptors must traverse the GolgiImmunity 32, March 26, 2010 ª2010 Elsevier Inc. 307
Figure 2. Trafficking and Processing
of Intracellular TLRs
Within the endoplasmic reticulum (ER) lumen,
gp96 promotes the proper folding of TLR3, TLR7,
and TLR9. Gp96, a chaperone similar to Hsp90,
functions as a V-shaped dimer that requires intact
ER Ca2+ stores and N-glycosylation for TLR inter-
action; ATP hydrolysis (not depicted) is dis-
pensable for binding the TLR but may be neces-
sary for its release. Both PRAT4A and the 12
transmembrane-spanning UNC93B1 are required
for TLR3, TLR7, and TLR9 to exit the ER, although
their precise functions remain unknown. TLR7 and
TLR9 compete for binding to UNC93B1, which
normally binds preferentially via an N-terminal
region to TLR9. The TLRs traffic through the Golgi
by the conventional secretory pathway and are
routed to endosomes where they can encounter
their ligands. TLR7 and TLR9 are cleaved within
their ectodomains by lysosomal cysteine prote-
ases, including the papain-related cathepsins
(CTS) K, L, and S, and asparagine endopeptidase
(AEP), a protease related to the caspase family and
the bacterial endopeptidase gingipain. Cleavage
of TLR7 and TLR9 is not strictly required for ligand
interaction but is essential for interaction with
MyD88 and subsequent signaling. Cleavage of
TLR3 has not been observed.
Immunity
Reviewapparatus, revealing that intracellular TLRs traffic from the ER via
the common secretory pathway through the Golgi to take up
residence in the endolysosomes prior to stimulation (Chockalin-
gam et al., 2009; Ewald et al., 2008; Park et al., 2008).
The intracellular localization of TLR3 is dictated by a region
between the Toll/IL-1 receptor (TIR) domain and the transmem-
brane domain, while intracellular localization of TLR7 and TLR9
depend upon their transmembrane domains. TLR3 is located
predominantly within the early endosomes, with cell-surface
expression observed in a few cell types (Funami et al., 2004;
Matsumoto et al., 2003). Although TLR3, TLR7, and TLR9 can
share the same intracellular compartment (Nishiya et al., 2005),
it has not been excluded that some compartments contain
more restricted TLR subsets and perhaps even single types of
these TLRs. Much of the work on localization and function of
intracellular TLRs has been focused on TLR9 under the
presumption that the rules governing TLR7 and TLR3 localization
will be similar, yet this remains to be tested.
Several chaperone proteins associate with TLRs in the ER and
are required for efficient translocation (Figure 2). Gp96 (also
known as Grp94), the ER paralog of the Hsp90 family, acts as
an ER chaperone for IgGs, some integrins, and TLRs. Macro-
phages lacking gp96 do not respond to ligands for TLRs 1, 2,
4, 5, 7, or 9 (Randow and Seed, 2001; Yang et al., 2007a).
N-glycosylation of gp96 and intact ER Ca2+ stores are both
required for the TLR9-gp96 interaction (Yang et al., 2007a).
PRAT4A (also known as Cnpy3) traffics TLR1, TLR2, and TLR4308 Immunity 32, March 26, 2010 ª2010 Elsevier Inc.from the ER to the plasma membrane
and TLR7 and TLR9 from the ER to the
endolysosome but does not appear
necessary for TLR3 trafficking (Takahashi
et al., 2007).
Using a forward genetic screening
approach, the 3d (‘‘triple defect’’ ofnucleic acid sensing) mutation was detected and homozygotes
were seen to be incapable of responding to ligands for TLR3,
TLR7, and TLR9. The 3d phenotype was ascribed to a mutation
in Unc93Bb1, a gene encoding a twelve membrane-spanning
protein residing chiefly in the ER (Tabeta et al., 2006).
UNC93B1 associates with TLR3, TLR7, TLR9, and TLR13 as
a result of direct interaction with their transmembrane domains
and mediates translocation of these intracellular TLRs from the
ER to the endolysosomes (Brinkmann et al., 2007; Kim et al.,
2008). TLR7 and TLR9 compete for association with
UNC93B1 (Fukui et al., 2009), while TLR3 appears unaffected
by this rivalry. Under normal circumstances, UNC93B1 associ-
ates more strongly with TLR9, favoring its translocation while
biasing against translocation of TLR7. This results in more
robust signaling through TLR9 and weaker TLR7 responses.
Indeed, overexpression of TLR9 inhibits TLR7 signaling (Wang
et al., 2006a). This preference for TLR9 is mediated by an N
terminal domain in UNC93B1, and an Unc93b1 deletion mutant
lacking this N terminal domain associates more tightly with
TLR7 and less tightly with TLR9. TLR3 appears to translocate
to the endosomal compartment with equal efficiency irrespec-
tive of the presence or absence of the N-terminal domain that
mediates preference for TLR9. Thus, UNC93B1 is ultimately
required for intracellular TLR responses and also determines
how efficiently each TLR is able to move from the ER to the
endolysosomes where they encounter and respond to their
respective ligands.
Figure 3. Intracellular TLR Signaling
Pathways
TLR3, TLR7, or TLR9 activation by nucleic acids
within endolysosomes initiates distinct and over-
lapping signaling cascades in cDCs, macro-
phages, and pDCs. Ligand binding to the LRRs
of TLRs is thought to induce a conformational
change that allows homophilic binding between
the TIR domains of receptors and the adapters
MyD88 or TRIF. To elicit proinflammatory cyto-
kines (center), MyD88 recruits IRAK4 through
death domain interactions. IRAK4 phosphorylates
IRAK1 and IRAK2 that, in turn, activate the E3
ubiquitin ligase TRAF6, which together with
UBC13 and UEV1A (not depicted), polyubiquiti-
nates NEMO and itself. TRAF6 also activates
TAK1. The TAK1-associated TAB2 protein serves
as a receptor for the polyubiquitin chains on
TRAF6 and NEMO and holds these proteins
together. TAK1 phosphorylates IKKb leading to
IkB degradation and release of NF-kB. TAK1 also
activates MAPKK3 and MAPKK6, resulting in
phosphorylation of JNKs, p38, and CREB. The
IKK complex can also phosphorylate p105, which
undergoes degradation, leading to the activation
of MAP3K8, MKK1, MKK2, ERK1, ERK2, and
JNK, culminating in activation of AP1 (not de-
picted). IRF1 and IRF5 become activated following
direct association with MyD88. IRFs, NF-kB, and
AP-1 transcription factors induce transcription of
proinflammatory cytokines, such as TNF and IL-
12. In cDCs and macrophages, signaling from
TLR3 (left) induces IFNb through TRIF, TRAF6,
and RIP1, a complex that associates with TRAF3
to activate TBK1 and IKK3, which, in turn, phos-
phorylate IRF3. Upon TLR3 activation, TRAF6
and RIP1 can also activate NF-kB and MAPKs to
induce proinflammatory cytokines (not depicted).
pDCs utilize a distinct pathway to induce large amounts of type I IFN (right). Activation of TLR7 or TLR9 in pDCs recruits MyD88 and IRAK4, which then interact
with TRAF6, TRAF3, IRAK1, IKKa, osteopontin (OPN), and IRF7. IRAK-1 and IKKa phosphorylate and activate IRF7, leading to transcription of interferon-inducible
genes and production of type I IFN.
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TLR3, TLR7, and TLR9 activation by purified ligands (Ha¨cker
et al., 1998). Endosome maturation may in some cases facilitate
disassembly of microbes in order to release the ligands con-
tained within them but may also contribute to essential process-
ing of the TLRs themselves. For example, upon reaching the
endolysosomal compartment, the TLR9 ectodomain is proteo-
lytically cleaved by proteases (Figure 2) (Ewald et al., 2008;
Park et al., 2008). Thus, full-length TLR9 is found only in the
ER, whereas the cleaved, biologically active product is restricted
to endolysosomes. Multiple proteases have been implicated in
TLR9 cleavage, including various cathepsins and asparagine
endopeptidase (Asagiri et al., 2008; Ewald et al., 2008; Fukui
et al., 2009; Matsumoto et al., 2008; Park et al., 2008; Sepulveda
et al., 2009), but it is likely that there is at least some redundancy
with respect to protease utilization, and the choice of protease
may be dependent on cell type. Although not essential, cleavage
increases binding to CpG DNA. TLR9 cleavage is required for
the recruitment of MyD88 and initiation of signal transduction.
Thus, cleavage appears to be an additional step of compart-
mental regulation limiting TLR-mediated signaling to a specific
class of endosomes. Although similar cleavage of TLR7 has
been reported by Ewald et al. (Asagiri et al., 2008; Ewald et al.,
2008; Fukui et al., 2009; Matsumoto et al., 2008; Park et al.,
2008), no cleavage of TLR3 has been observed. Postcleavageforms of TLR7 and TLR9 may take on a structure similar to the
ligand binding solenoid shape of full-length TLR3 (Bell et al.,
2005; Ewald et al., 2008; Liu et al., 2008).
TLR Signaling
All TLRs, with the exception of TLR3, depend at least in part upon
the MyD88 adaptor protein for full signaling activity, and some
TLRs (including TLRs 7 and 9) are completely dependent upon
MyD88. Ligand binding to the leucine rich repeats (LRRs) in the
ectodomain induces a change in the conformation and/or asso-
ciation of TLR ectodomains that is believed, in turn, to affect the
association of the cytoplasmic TIR domains (Latz et al., 2007),
eliciting a signal. Signaling entails association between TIR
domains of the TLRs and TIR domains of adaptor molecules,
but no crystallographic data have yet permitted a detailed under-
standing of these events. Certain mutations in MyD88 produce
receptor-selective effects (Jiang et al., 2006), and while some
parts of the MyD88 TIR domain are important to permit its
recruitment to a specific TLR, other parts are required for prop-
agation of the signal downstream (Dunne et al., 2003; Li et al.,
2005). MyD88 contains an N-terminal death domain (DD), which
interacts with IL-1R-associated kinase-4 (IRAK-4) through its
own DD (Figure 3) (Suzuki et al., 2002). IRAK4 phosphorylates
IRAK1 and IRAK2 (Kawagoe et al., 2008); they in turn activate
TNF receptor-associated factor 6 (TRAF6), which is inhibitedImmunity 32, March 26, 2010 ª2010 Elsevier Inc. 309
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2002). TRAF6, an E3 ubiquitin ligase, combined with UBC13
and UEV1A forms polyubiquitin chains on NF-kB essential
modulator (NEMO or IKKg) (Siggs et al., 2010; Skaug et al.,
2009) and on itself. TRAF6 also activates the MAPKKK member
TGF-b activated kinase 1 (TAK1), which associates with two
adaptor proteins: TAK1-binding proteins 1 (TAB1) and TAB2.
TAB2 serves as a receptor for the polyubiquitin chains on
TRAF6 and NEMO and ‘‘glues’’ these proteins together. TAK1
phosphorylates IKKb and also activates a cascade of mitogen-
activated kinases (MAPKs), starting with MAPKK3 and MAPKK6,
leading to phosphorylation of Jun kinases (JNKs), p38, and ulti-
mately, CREB. The IKK proteins phosphorylate IkBs, resulting in
their degradation and resultant nuclear translocation of NF-kB.
They additionally phosphorylate p105, another member of the
NF-kB family, which undergoes degradation, leading to the acti-
vation of MAP3K8. MAP3K8, also known as Tpl2, is a protein
kinase that activates MKK1 and MKK2, which in turn activate
extracellular signal regulated kinases ERK1 and ERK2 and the
Jun kinases (JNK), culminating in activation of AP1. The IRF
family of transcription factors is also activated. IRF1 associates
directly with MyD88 (Negishi et al., 2006), and IRF5 associates
with both MyD88 and TRAF6 (Takaoka et al., 2005). Ultimately,
activation of IRFs, NF-kB, and AP-1 transcription factors induces
gene transcription of proinflammatory cytokines, such as TNF
and IL-12.
TLR3 does not signal through MyD88 but instead associates
with the adaptor TRIF (Hoebe et al., 2003). TRIF associates
with TRAF3 and TRAF6, as well as receptor-interacting proteins
1 and 3 (RIP1 and RIP3). TRAF6 and RIP1, with the help of
TRADD and TAK1, activate NF-kB and MAPKs to induce proin-
flammatory cytokines (Ermolaeva et al., 2008; Pobezinskaya
et al., 2008). TRAF3 links TBK1 to the TRIF-dependent pathway
(Ha¨cker et al., 2006), which in combination with IKK3, phosphor-
ylates and activates IRF3 (Fitzgerald et al., 2003; Sharma et al.,
2003), leading to IFNb production. TLR4 also signals through
the same TRIF pathway but, under most circumstances, addi-
tionally requires the adaptor TRAM.
Although TLR3, TLR7, TLR8, and TLR9 are localized and act
exclusively from intracellular compartments, other TLRs may,
in some instances, also signal from locations within the cell.
TLR4 ligand recognition occurs at the cell surface, resulting in
recruitment and signaling through MyD88. Subsequently,
receptor internalization into early endosomes halts MyD88-
dependent signaling and triggers TRIF-dependent signaling
(Husebye et al., 2006; Kagan et al., 2008; Tanimura et al.,
2008). Finally, TLR4 migrates to late endosomes, where it
encounters TAG, a splice variant of TRAM that disrupts the inter-
action between TRIF and TRAM, arresting TRIF-dependent
signaling and ultimately promoting degradation of the signaling
complex (Palsson-McDermott et al., 2009). TLR2 is also internal-
ized following ligand binding, but in this case, MyD88-dependent
signaling continues from an intracellular location away from
the plasma membrane and stimulates type I IFN production
through an as yet unknown mechanism (Barbalat et al., 2009).
These data suggest that TRIF signals strictly from an intracel-
lular location, whereas MyD88 can signal both when associ-
ated with the plasma membrane and from within endosomal
compartments.310 Immunity 32, March 26, 2010 ª2010 Elsevier Inc.TLR7 and TLR9 Signaling in Plasmacytoid Dendritic
Cells
Plasmacytoid dendritic cells (pDCs) are unique in their ability to
couple TLR7 and TLR9 signaling with production of abundant
quantities of type I IFN. The signaling events described above
occur in macrophages, conventional dendritic cells (cDCs), B
cells, and pDCs and lead to production of proinflammatory
cytokines, such as TNFa, IL-6 and IL-12, but not type I IFN. In
pDCs, however, an additional pathway exists (Figure 3): activa-
tion of TLR7 or TLR9 recruits MyD88 and IRAK4, which then
interact with TRAF6, TRAF3, IRAK1, IKKa, osteopontin, and
IRF7 (Kawai et al., 2004; Shinohara et al., 2006). Ultimately,
IRAK-1 and IKKa phosphorylate IRF7, leading to activation,
which induces abundant transcription of type I IFN genes and
production of enormous quantities of type I IFN (Honda et al.,
2005b).
It is presently unclear whether both signaling pathways, one
leading to proinflammatory cytokine production and the other
to type I IFN production, occur simultaneously or sequentially.
Furthermore, it is not understood how and why pDCs are able
to utilize this unique pathway to generate large amounts of
type I IFN in response to TLR signaling through MyD88. Reten-
tion of the signaling complex within the early endosome in
pDCs, as opposed to the late endosome or lysosome in other
immune cells, appears to correlate with IRF-7 recruitment and
IFN induction (Honda et al., 2005a), suggesting that TLR
signaling from early endosomes is different in nature than that
from late endosomes. The nature of this difference remains
unknown but may be due to altered pH or inclusion of additional
signaling molecules not present in more mature compartments.
Alternatively or in conjunction with this idea, it has been
proposed that basal induction of IRF7 in pDCs allows these cells
to quickly produce large amounts of type I IFN (Honda et al.,
2005b). It could be that other adaptations unique to pDCs have
been built around the TLR sensing and signaling apparatus to
augment the interferon response.
Two types of synthetic CpG ODN induce differential cytokine
responses from immune cells. For pDCs, Type ‘‘A’’ CpG ODN
(CpG-A) mainly induce type I IFN, whereas type ‘‘B’’ CpG ODN
(CpG-B) predominantly induce proinflammatory cytokines. In
structural terms, CpG-B contain single or multiple CpG motifs
on a phosphorothioate backbone. These CpG-B molecules
remain as single-stranded linear monomers, allowing them to
traffic rapidly to the endosome and lysosome (Guiducci et al.,
2006; Honda et al., 2005a). On the other hand, CpG-A contain
a single CpG motif and a 30 poly-G tail on a mixed phosphoro-
thioate-phosphodiester backbone, which mediate aggregation
of CpG-A resulting in a longer retention time in the early endo-
some (Kerkmann et al., 2005). It is thought that this prolonged
period in the early endosome results in extended activation of
the MyD88-TRAF6-IRAK1-IRF7 complex and thereby promotes
robust type I IFN production, as discussed above. Differential
responses of pDCs to CpG-A and CpG-B were thus proposed
to stem from detection of CpG-A and CpG-B in distinct compart-
ments. However, it is unclear whether CpG ODN trafficking
conforms to the physiological trafficking pathways for microbial
molecules. Viral nucleic acids likely stimulate cells in a manner
more similar to CpG-A, as has been shown for influenza
virus stimulation of TLR7 (Di Domizio et al., 2009). Thus, the
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and the implications concerning responses to DNA derived from
infectious agents remain ambiguous, although it is clear that
pDCs are specialized for the generation of abundant quantities
of type I IFN in response to both artificial and microbial ligands
for TLR7 and TLR9.
By comparing the signaling pathways utilized by cell-surface
TLRs with those of intracellular TLRs, as well as other intracel-
lular receptors, a unifying picture emerges that the location
of the receptor dictates the signal produced. Type I IFN is
produced solely by recognition of ligands present in the cytosol
or within the lumen of intracellular compartments. In part, this
reflects the compartmentalization of signaling adaptors and
proteins. The most striking example of this is TRAF3, which is
the only signaling component shared by all the interferon-
inducing signaling pathways (Saha and Cheng, 2006). Notably,
signaling that elicits type I IFN production through the TLR3/
TRIF axis, TLR4/TRIF axis, or the TLR2/MyD88 axis probably
occurs within early endosomal compartments. Further studies
will establish whether the early endosome indeed represents
the sole compartment from which type I IFN may be induced
by TLR signaling.
Compartment-Based Ligand Recognition Is Key
to Distinguishing Self from Foreign Nucleic Acids
Nucleic acid sequences are the targets of choice for sensing
viruses. Nucleic acids are critical viral components present
throughout the viral life cycle. Viral nucleic acids display features
that permit discrimination from host nucleic acids, including long
dsRNA, 50-triphosphate RNA, and unmethylated CpG DNA,
which can serve as triggers for innate immune receptors. None-
theless, physical separation of host nucleic acids from foreign
nucleic acids and the intracellular receptors that detect them is
the key to distinguishing self from invader.
Proper trafficking of TLR7, TLR8, and TLR9 is essential to
prevent receptor activation by self DNA, leading to autoimmu-
nity. Host DNA introduced into the endosomal compartment
using a liposomal transfection reagent can stimulate TLR9
(Yasuda et al., 2006). Conversely, forced expression of TLR9 at
the cell surface permits cells to bind self DNA within the extracel-
lular space and blocks sensing of viral DNA (Barton et al., 2006).
Thus, altering receptor compartmentalization would be pre-
dicted to permit access to host DNA within the extracellular
milieu while preventing access to endosome-protected viral
ligands. It is now known that TLR9 cleavage is required for
efficient ligand binding and association with MyD88. It is not
clear how a surface-directed TLR9 complex would undergo pro-
cessing to make it competent to signal. Potentially, ectopically
expressed TLR9 might cycle or recycle through endosomal
compartments, allowing cleavage to occur.
Under normal circumstances, host DNA is sequestered in
nuclei or mitochondria, and extracellular and endosomal DNases
and RNases hydrolyze free nucleic acids, preventing inappro-
priate activation of the innate immune system. Accordingly,
nuclease-resistant phosphorothioate-stabilized or 30-polygua-
nosine oligonucleotides are especially strong activators of
TLR9 (Haas et al., 2008; Yasuda et al., 2006). Special mecha-
nisms may normally shield sensing systems of the cell from
DNA during apoptosis, when it might otherwise be exposed toinnate immune receptors as the nuclear membrane breaks
down. DNA is most likely degraded as the cell is transformed
into apoptotic bodies. In this way, cells and their endogenous
TLR ligands are silently eliminated.
Intracellular Nucleic Acid Sensing and Autoimmunity
Nucleic acid sensing pushes self-nonself discrimination to its
limits and has come to depend upon physical separation of
host nucleic acids from the innate immune receptors that would
otherwise detect them. Autoimmune or autoinflammatory dis-
eases develop when self DNA comes into contact with intracel-
lular TLRs or other cytoplasmic nucleic acid sensors. Activation
of intracellular TLRs, in particular TLR7 and TLR9, have been
implicated in the production of autoantibodies to nuclear and
cytoplasmic material containing RNA and/or DNA in mice with
systemic lupus erythematosus (SLE)-like disease (Marshak-
Rothstein, 2006). In lupus-prone BXSB mice, the Y-linked accel-
erator of autoimmunity (Yaa) locus encodes an extra copy of
TLR7 on the Y chromosome, a circumstance that markedly
accelerates the progression of a lupus-like disorder. Yaa has a
general effect, promoting SLE progression in other lupus-prone
strains as well. Sequential engagement of cell surface BCR
and endosomal TLRs is necessary and sufficient for autoanti-
body production. B cell autoreactivity may also be promoted
by nucleic acid sensing in accessory cells. For example, it has
been shown that interplay between pDCs and B cells is required
for full activation of autoreactive B cells upon TLR or BCR
stimulation (Ding et al., 2009).
Untoward encounters between host nucleic acids and host
nucleic acid sensors may occur when the former escape degra-
dation during programmed cell death. Dysfunction of Flap
endonuclease 1 (FEN1) has been shown to result in residual
undigested self DNA within apoptotic bodies leading to chronic
inflammation and autoimmunity (Zheng et al., 2007). Deficiencies
in extracellular DNase I results in a SLE-type syndrome in mice
(Napirei et al., 2000). Additionally, human SLE patients exhibit
lower serum DNase I activity and some mutations within the
DNase I gene have been identified (Yasutomo et al., 2001).
Dysfunction of lysosomal DNase II also results in inadequate
degradation of DNA, leading to a variety of autoimmune
syndromes including arthritis and anemia (Kawane et al., 2006;
Okabe et al., 2005; Yoshida et al., 2005). The Trex1 endonu-
clease mediates DNA degradation during granzyme A-mediated
cell death, and mutations of human TREX1 result in SLE, familial
chilblain lupus, inflammatory myocarditis, and Aicardi-Goutieres
syndrome (Crow et al., 2006; Lee-Kirsch et al., 2007a, 2007b). In
mice, targeted deletion of Trex1 results in reduced lifespan and
inflammatory myocarditis and cardiomyopathy by 2–4 months
of age (Morita et al., 2004). An IRF-3-dependent type I IFN
response was shown to be required for development of inflam-
matory myocarditis. In Trex1-deficient cells, 60–65 bp ssDNAs
accumulate in the ER, leading to activation of the ataxia telangi-
ectasia mutated (ATM)-dependent DNA damage checkpoint
(Yang et al., 2007b). Cloning of the accumulated Trex1 sub-
strates suggests that Trex1 may degrade reverse transcribed
DNA arising from endogenous retroelements (Stetson et al.,
2008).
Complexing of host proteins and nucleic acids may prevent
degradation of nucleic acids as it normally occurs or may permitImmunity 32, March 26, 2010 ª2010 Elsevier Inc. 311
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Higher concentrations of nucleic acid ligands, shorter transit
times, trafficking by a different route, or longer retention times
within the endosomal compartment may also result. TLR9
responses in B cells are triggered following BCR-mediated
uptake of proteins complexed to nucleic acids (Lau et al.,
2005; Leadbetter et al., 2002). The antimicrobial peptide LL37
released during skin injury binds to self DNA released during
tissue damage and creates aggregates that enter the endosomal
pathway and are retained there. Although this likely boosts
resistance to infection under normal circumstances, when
LL37 is aberrantly expressed, it can result in autoimmunity
manifesting as psoriasis (Lande et al., 2007). Anti-nuclear
antibodies may form complexes with self DNA-bound nuclear
proteins if tolerance to nuclear components is lost, thereby facil-
itating FcR mediated self DNA uptake into endosomes where it
can activate TLR signaling (Boule´ et al., 2004).
Perspectives
Many essential questions regarding intracellular innate sensing
remain unanswered. First, we would like to know the essential
biochemical distinctions between intracellular and cell-surface
signaling and their structural bases. And these distinctions may
be exceptionally complex, insofar as the machinery built around
TLRs differs from one cell type to another. Witness the difference
in signaling in macrophages as compared to pDCs for example.
Comparable differences—or perhaps greater ones—may distin-
guish TLR signaling in other cells types (e.g., epithelial cells,
neurons, and fibroblasts) where TLRs certainly exist and do
respond to ligands but have been less studied than they have
been in immune cells.
Although much progress has been made in recent years,
mechanistic details regarding trafficking of intracellular recep-
tors, their ligands, and associated signaling molecules remain
unclear. A few of the molecular requirements (e.g., UNC93B1
and gp96) are known, but many more remain to be defined,
and we are far from a detailed understanding. One pathway
to progress is forward genetic analysis of the TLR response
(Beutler and Moresco, 2008). Screens of ENU mutagenized
animals have disclosed components of the signaling apparatus
that might otherwise have escaped notice. Subsequent place-
ment of these components within pathways and decipherment
of their modes of action has allowed some of the most surprising
advances in the field. The forward genetic strategy could be
used to specifically probe intracellular recognition. A screen for
impaired production of type I IFN, conducted in pDCs activated
by TLR7 or TLR9 or macrophages stimulated with TLR3, might
be entertained for this reason. Similarly, screens designed to
detect the impairment of RLH and NLR signaling could readily
be exploited to find new molecules. As essential molecules are
identified, we may hope to entertain hypotheses about their
precise relationship to one another, and their roles in self-nonself
discrimination.
In conclusion, the intracellular TLRs represent a unique system
by which infection is detected through recognition of nucleic
acids. Differential compartmentalization of TLRs dictates not
only which ligands are recognized, but also the nature of the
signals generated. Thus, a complex regulatory system exists to
ensure that both ligands and receptors are properly localized.312 Immunity 32, March 26, 2010 ª2010 Elsevier Inc.Ultimately, a delicate balance exists whereby deviations can
result in immune deficiency on one side or autoimmunity on
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